Septerna Announces Novel GPCR-targeted Program Acquired by Vertex
Read More
Septerna 250 East Grand Avenue, Suite 65 South San Francisco, CA 94080
Archive for Uncategorized
Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted Medicines
Read More
Privacy Policy
Read More
Terms of Use
Read More